Hepatology - Google Scholar Metrics

h5-index:126
h5-median:181

h5-index is the h-index for articles published in the last 5 complete years. It is the largest number h such that h articles published in 2014-2018 have at least h citations each.hide

h5-median for a publication is the median number of citations for the articles that make up its h5-index.hide

#2 Gastroenterology & Hepatology

Title / Author	Cited by	Year
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes ZM Younossi, AB Koenig, D Abdelatif, Y Fazel, L Henry, M Wymer Hepatology 64 (1), 73-84	1672	2016
Global distribution and prevalence of hepatitis C virus genotypes JP Messina, I Humphreys, A Flaxman, A Brown, GS Cooke, OG Pybus, ... Hepatology 61 (1), 77-87	1196	2015
A ASLD guidelines for treatment of chronic hepatitis B NA Terrault, NH Bzowej, KM Chang, JP Hwang, MM Jonas, MH Murad Hepatology 63 (1), 261-283	1066	2016
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource DB Smith, J Bukh, C Kuiken, AS Muerhoff, CM Rice, JT Stapleton, ... Hepatology 59 (1), 318-327	1059	2014
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver H Vilstrup, P Amodio, J Bajaj, J Cordoba, P Ferenci, KD Mullen, ... Hepatology 60 (2), 715-735	731	2014
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up M Ekstedt, H Hagström, P Nasr, M Fredrikson, P Stål, S Kechagias, ... Hepatology 61 (5), 1547-1554	730	2015
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases N Chalasani, Z Younossi, JE Lavine, M Charlton, K Cusi, M Rinella, ... Hepatology 67 (1), 328-357	631	2018
All‐oral 12‐week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY‐3 phase III study DR Nelson, JN Cooper, JP Lalezari, E Lawitz, PJ Pockros, N Gitlin, ... Hepatology 61 (4), 1127-1135	611	2015
AASLD guidelines for the treatment of hepatocellular carcinoma JK Heimbach, LM Kulik, RS Finn, CB Sirlin, MM Abecassis, LR Roberts, ... Hepatology 67 (1), 358-380	554	2018
Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection H Kumada, Y Suzuki, K Ikeda, J Toyota, Y Karino, K Chayama, ... Hepatology 59 (6), 2083-2091	526	2014
The global burden of liver disease: The major impact of China FS Wang, JG Fan, Z Zhang, B Gao, HY Wang Hepatology 60 (6), 2099-2108	500	2014
Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus AASLD/IDSA HCV Guidance Panel, RT Chung, GL Davis, DM Jensen, ... Hepatology 62 (3), 932-954	464	2015
Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 Diabetes AL Birkenfeld, GI Shulman Hepatology 59 (2), 713-723	384	2014
Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases G Garcia‐Tsao, JG Abraldes, A Berzigotti, J Bosch Hepatology 65 (1), 310-335	372	2017
Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go? HB El‐Serag, F Kanwal Hepatology 60 (5), 1767-1775	360	2014
Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post‐liver transplantation recurrence F Poordad, ER Schiff, JM Vierling, C Landis, RJ Fontana, R Yang, ... Hepatology 63 (5), 1493-1505	351	2016
Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the US RJ Wong, R Cheung, A Ahmed Hepatology 59 (6), 2188-2195	324	2014
Hepatic inflammation and fibrosis: Functional links and key pathways E Seki, RF Schwabe Hepatology 61 (3), 1066-1079	311	2015
Extrahepatic complications of nonalcoholic fatty liver disease MJ Armstrong, LA Adams, A Canbay, WK Syn Hepatology 59 (3), 1174-1197	305	2014
Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation P Martin, A DiMartini, S Feng, R Brown Jr, M Fallon Hepatology 59 (3), 1144-1165	304	2014

1 - 20

Dates and citation counts are estimated and are determined automatically by a computer program.